1-3 of 3
Najat Bouchkouj, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3450.
https://doi.org/10.1182/blood-2019-125798
Published: 2019
Journal Articles

A U.S. Food and Drug Administration Age Based Pooled Analysis of Cytokine Release Syndrome and Neurotoxicity in Subjects with Relapsed/Refractory Lymphoma Treated with Chimeric Antigen Receptor (CAR) T Cell Therapy

Poornima Sharma, MD, Harpreet Singh, MD, Najat Bouchkouj, MD, Aviva C. Krauss, MD, Bindu George, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4201.
https://doi.org/10.1182/blood-2018-99-115188
Published: 2018
Journal Articles

Dipeptidyl Peptidase Inhibition Alters Myeloid Derived Suppressor Cell Phenotype and Induces Regression of Pediatric Sarcomas.

Najat Bouchkouj, MD, Shannon Larabee, Haying Qin, Joanna Louise Meadors, BS, Crystal L Mackall, MD, Terry J Fry, MD
Journal: Blood
Blood (2010) 116 (21): 3792.
https://doi.org/10.1182/blood.V116.21.3792.3792
Published: 2010